Filing Details

Accession Number:
0001008310-10-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-08 12:00:00
Reporting Period:
2010-03-08
Filing Date:
2010-03-08
Accepted Time:
2010-03-08 17:40:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008310 D Peter Meldrum 320 Wakara Way
Salt Lake City UT 84108
President & C.e.o. Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-08 30,754 $8.86 232,583 No 4 M Direct
Common Stock Disposition 2010-03-08 30,754 $22.30 201,829 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-03-08 30,754 $0.00 30,754 $8.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-04-20 No 4 M Direct
Footnotes
  1. 20% vests annually beginning on the 1st anniversary of the date of the Option Grant.